Speaker illustration

Doctor Pierpaolo Pellicori

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

I am a clinical cardiologist currently working as a senior clinical research fellow in the Robertson Centre for Biostatistics at the University of Glasgow with an honorary consultant cardiologist contract with NHS Greater Glasgow and Clyde. I obtained my medical degree from Sapienza University in Rome and completed my specialist training in Cardiology in 2008 from the same institution. I spent my last 9 months of training abroad at a tertiary centre (RWTH University, Aachen, Germany) to improve my skills in advanced echocardiography. I subsequently worked for 6 months with an Italian Charity (Emergency) in Sudan and then applied for GMC registration before moving to the UK in 2010. Over the past ten years, I have combined both research and clinical duties. My current area of interest is the use of new imaging modalities as tool to quantify clinical congestion with greater precision.

Fluid responsiveness and congestion.

Event: EuroEcho 2019

Topic: Echocardiography, Other

Session: Non-invasive hemodynamic assessment in different contexts

Thumbnail

Body mass index or waist and hip circumference as predictors of outcome in the UK biobank

Event: ESC CONGRESS 2019

Topic: Epidemiology

Session: New approaches in risk stratification

Thumbnail

Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Heart failure: prognosis, outcome

Thumbnail

Relationship between congestion by ultrasound, body mass index and cardiac rhythm in ambulatory patients with heart failure

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Imaging

Session: Chronic Heart Failure – Diagnostic Methods

Thumbnail

What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Thumbnail

HsCRP in patients with heart failure and its associations with outcome

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure – epidemiology, prognosis, outcome

Thumbnail

Relationship of clinical congestion to biomarker activation and outcome in patients with heart failure: findings from BIOSTAT-CHF

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Clinical

Session: Congestion: how to detect with new technologies

Thumbnail

Relationship of circulating plasma levels of D-Dimer and outcome in patients with heart failure: findings from BIOSTAT-CHF

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pathophysiology and Mechanisms

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

How many patients with chronic heart failure will be eligible for LCZ696 in the community?

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Drug therapy, other

Thumbnail

Prevalence and incidence of atrial fibrillation in heart failure patients with either reduced or normal left ventricular ejection fraction

Event: HEART FAILURE 2016

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk